ALEXANDRIA, Va., June 25 -- United States Patent no. 12,336,996, issued on June 24, was assigned to Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (Lianyungang, China).
"Drug combination containing TLR7 agonist" was invented by Hongjiang Xu (Nanjing, China), Dandan Lu (Nanjing, China), Xingfeng Ge (Nanjing, China), Wei Song (Nanjing, China), Wei Shi (Nanjing, China), Ling Yang (Nanjing, China), Xiquan Zhang (Nanjing, China), Hao Yu (Nanjing, China) and Zhongnan Xu (Nanjing, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "A drug combination containing a TLR7 agonist. Specifically, a drug combination jointly using the compound of formula I acting as a TLR7 agonist and entecavir for the treatment of hepat...